Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1996-12-23
pubmed:abstractText
We investigated the influence of hyperthyroidism on relaxant responses of small mesenteric resistance arteries to beta-adrenoceptor agonists and to compounds stimulating the corresponding second-messenger system. Hyperthyroidism was induced by feeding rats for 28 days with 5 mg/kg L-thyroxine (T4)-containing rat chow. This treatment produced a stable hyperthyroid state, as indicated by several biochemical/metabolic and haemodynamic parameters. Preparations of small mesenteric arteries were mounted in an isometric wire myograph. Subsequently, concentration-effect curves were determined for isoproterenol, noradrenaline and salbutamol as well as for forskolin, dibutyryl-cAMP and theophylline. We also determined concentration-effect curves to the beta-adrenoceptor agonists in the presence of ICI 118,551 and CGP 20712A (i.e., in the presence of a selective beta 2- and beta 1-adrenoceptor antagonist, respectively). Apparent pA2-values were calculated to determine which beta-adrenoceptor subtype causes vasodilation. These experiments indicate that beta-adrenoceptor-mediated vasodilation involves both beta 1- and beta 2-adrenoceptors in mesenteric resistance vessels of both hyperthyroid and control rats. In our experiments hyperthyroidism has a sensitizing influence on vascular responses induced by the beta-adrenoceptor agonist isoproterenol and the selective beta 2-adrenoceptor agonist salbutamol. Sensitization to isoproterenol was abolished in the presence of ICI 118,551, whereas it was emphasized in the presence of CGP 20712A. Although this was not fully supported by the results obtained with noradrenaline, these results indicate that the sensitization to beta-adrenoceptor agonists is probably limited to the beta 2-adrenoceptor/G-protein complex and not associated with alterations of the corresponding second messenger system.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/15-Hydroxy-11 alpha,9..., http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Albuterol, http://linkedlifedata.com/resource/pubmed/chemical/CGP 20712A, http://linkedlifedata.com/resource/pubmed/chemical/Forskolin, http://linkedlifedata.com/resource/pubmed/chemical/ICI 118551, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol, http://linkedlifedata.com/resource/pubmed/chemical/Methoxamine, http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin Endoperoxides..., http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane A2, http://linkedlifedata.com/resource/pubmed/chemical/Thyroxine, http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0028-1298
pubmed:author
pubmed:issnType
Print
pubmed:volume
353
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
438-44
pubmed:dateRevised
2009-11-3
pubmed:meshHeading
pubmed-meshheading:8935711-15-Hydroxy-11 alpha,9..., pubmed-meshheading:8935711-Adrenergic alpha-Agonists, pubmed-meshheading:8935711-Adrenergic beta-Agonists, pubmed-meshheading:8935711-Adrenergic beta-Antagonists, pubmed-meshheading:8935711-Albuterol, pubmed-meshheading:8935711-Animals, pubmed-meshheading:8935711-Dose-Response Relationship, Drug, pubmed-meshheading:8935711-Forskolin, pubmed-meshheading:8935711-Hyperthyroidism, pubmed-meshheading:8935711-Imidazoles, pubmed-meshheading:8935711-Isoproterenol, pubmed-meshheading:8935711-Male, pubmed-meshheading:8935711-Mesenteric Arteries, pubmed-meshheading:8935711-Methoxamine, pubmed-meshheading:8935711-Muscle Contraction, pubmed-meshheading:8935711-Muscle Relaxation, pubmed-meshheading:8935711-Propanolamines, pubmed-meshheading:8935711-Prostaglandin Endoperoxides, Synthetic, pubmed-meshheading:8935711-Rats, pubmed-meshheading:8935711-Rats, Wistar, pubmed-meshheading:8935711-Thromboxane A2, pubmed-meshheading:8935711-Thyroxine, pubmed-meshheading:8935711-Vascular Resistance, pubmed-meshheading:8935711-Vasoconstrictor Agents
pubmed:year
1996
pubmed:articleTitle
The influence of hyperthyroidism on beta-adrenoceptor-mediated relaxation of isolated small mesenteric arteries.
pubmed:affiliation
Department of Pharmacotherapy, University of Amsterdam, Netherlands.
pubmed:publicationType
Journal Article